WHWK: שווי חברה לרווח נקי aadibio.com
The price chart on the GURU.Markets platform helps assess the management efficiency of the precision oncology expert team, where the indicator stands at -2.10. The Aadi Bioscience Inc (WHWK) business relies on the development of albumin-based drugs for targeted therapy delivery to tumors. Aadi Bioscience Inc (WHWK) generates revenue from stable demand from oncology centers, focusing on the treatment of rare sarcomas and expanding its therapeutic spectrum.
%20%D7%9E%D7%9B%D7%A4%D7%99%D7%9C%20P%2FE&width=1200&height=400&colorIndex=0&v=mwbxec28.yq-7cu2wow&start=20220704&end=20261111&filename=GURU_Markets_-_WHWK_-_Aadi-Bioscience-Inc_-_PE-Multiple "WHWK: מקדם מחיר לרווח Aadi Bioscience Inc 20.03.2025 - 11.11.2026 | 👁️GURU.Markets👁️")
פילוחי מדדים מקיפים ואנליטיקה עבור Aadi Bioscience, Inc. (WHWK)
The P/E ratio determines the cost of one dollar of net profit, reflecting the proportion between market capitalization and the actual financial result of the business. Analyzing the current P/E multiple valuation allows for an assessment of overpayment risks, which is critical for Aadi Bioscience Inc. (WHWK), whose future excess profits depend on the scalability of low-cost targeted therapy production following regulatory approval.
